Stay updated on Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial
Sign up to get notified when there's something new on the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page.

Latest updates to the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedNew revision marker appears: Revision: v3.6.5 replaces v3.6.4, indicating a small update to the page's revision record.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page footer now displays Revision: v3.6.4, replacing the previous Revision: v3.6.3. This reflects a small update to the page template or backend without changing the study details shown.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating a minor update to the page's version. The change likely reflects backend or CMS maintenance rather than new study data.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision: v3.6.2 is shown in the page footer, replacing the previous v3.6.0. This reflects a minor update to the page version metadata.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page now shows recruitment is closed with the message 'No longer looking for participants' and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The revision label was updated to v3.6.0 from v3.5.5.SummaryDifference0.4%

- Check81 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, signaling a minor software/UI update. It does not indicate changes to study content or data.SummaryDifference0.1%

Stay in the know with updates to Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page.